转移性结直肠癌的治疗顺序
Nanteznta Torounidou1, Melina Yerolatsite1, George Zarkavelis1,2
1Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
Contemporary oncology (Poznan, Poland)
|February 12, 2025
概括
优化转移性结直肠癌 (mCRC) 的治疗顺序对于改善患者的治疗结果至关重要. 本综述探讨了包括化疗,向疗法和免疫疗法在内的当前策略,以最大限度地提高mCRC护理的临床益处.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 转移性结直肠癌 (mCRC) 尽管取得了进展,但仍存在重大治疗挑战.
- 目前的疗法提高了生存率,但第四阶段疾病的预后仍然很差.
研究的目的:
- 在mCRC中全面审查当前的治疗序列化策略.
- 阐明各种治疗方法的理由和证据.
主要方法:
- 关于mCRC治疗序列的当前文献的综述.
- 化疗,向治疗和免疫治疗作用的分析.
- 探索个性化医学和顺序治疗趋势.
主要成果:
- 治疗顺序对于mCRC患者的治疗结果至关重要.
- 一种"持续护理"的方法使治疗个性化,以最大限度地获得益处.
- 不断发展的证据支持各种顺序治疗方案.
结论:
- 在mCRC中优化治疗策略需要理解复杂的测序.
- 个性化的方法和持续的护理对于改善患者护理和结果至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K